Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2025 Jul;23(7):e250033.
doi: 10.6004/jnccn.2025.0033.

NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025

Robert I Haddad  1 , Lindsay Bischoff  2 , Megan Applewhite  3 , Victor Bernet  4 , Erik Blomain  5 , Maria Brito  6 , Naifa Lamki Busaidy  7 , Michael Campbell  8 , Olivia DeLozier  9 , Quan-Yang Duh  10 , Hormoz Ehya  11 , Erin Grady  5 , Theresa Guo  12 , Megan Haymart  13 , Jason P Hunt  14 , Fouad Kandeel  15 , Anupam Kotwal  16 , Dominick M Lamonica  17 , Jochen Lorch  18 , Susan J Mandel  19 , Stephanie Markovina  20 , Wojciech Mydlarz  21 , Lisle Nabell  22 , Christopher D Raeburn  23 , Rod Rezaee  24 , John A Ridge  11 , Hadley Ritter  25 , Mara Y Roth  26 , Sarimar Agosto Salgado  27 , Randall P Scheri  28 , Jatin P Shah  29 , Jennifer A Sipos  30 , Rebecca Sippel  31 , Cord Sturgeon  18 , Lori J Wirth  1 , Richard J Wong  29 , Francis Worden  13 , Michael W Yeh  32 , Susan Darlow  33 , Carly J Cassara  33 , Bailee Sliker  33
Affiliations
Practice Guideline

NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025

Robert I Haddad et al. J Natl Compr Canc Netw. 2025 Jul.

Abstract

The NCCN Guidelines for Thyroid Carcinoma address the management of different types of thyroid carcinoma, including papillary, follicular, oncocytic, medullary, and anaplastic carcinoma. The NCCN Thyroid Carcinoma Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on the panel's most recent recommendations regarding systemic therapies for thyroid carcinoma as well as the supporting clinical data.

PubMed Disclaimer

Similar articles

  • NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.
    Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Howitt BE, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nieto K, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam V. Abu-Rustum NR, et al. J Natl Compr Canc Netw. 2025 Aug;23(8):284-291. doi: 10.6004/jnccn.2025.0038. J Natl Compr Canc Netw. 2025. PMID: 40763788
  • NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
    Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA. Haddad RI, et al. J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089. J Natl Compr Canc Netw. 2018. PMID: 30545990
  • NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
    Benson AB 3rd, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S. Benson AB 3rd, et al. J Natl Compr Canc Netw. 2017 May;15(5):563-573. doi: 10.6004/jnccn.2017.0059. J Natl Compr Canc Netw. 2017. PMID: 28476736 Free PMC article.
  • Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer.
    Huang TW, Lai JH, Wu MY, Chen SL, Wu CH, Tam KW. Huang TW, et al. BMC Med. 2013 Aug 29;11:191. doi: 10.1186/1741-7015-11-191. BMC Med. 2013. PMID: 23987922 Free PMC article.
  • Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
    Trimboli P, Guidobaldi L, Bongiovanni M, Crescenzi A, Alevizaki M, Giovanella L. Trimboli P, et al. Diagn Cytopathol. 2016 Jan;44(1):45-51. doi: 10.1002/dc.23375. Epub 2015 Oct 19. Diagn Cytopathol. 2016. PMID: 26481456
See all similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources